BioCentury
ARTICLE | Company News

FTC suit alleges Shire abused FDA process

February 8, 2017 12:51 AM UTC

In a federal lawsuit, the U.S. Federal Trade Commission alleged that the Shire ViroPharma Inc. subsidiary of Shire plc (LSE:SHP; NASDAQ:SHPG) abused the Citizen's Petition process and violated antitrust laws to delay generic competition for antibiotic Vancocin vancomycin.

The FTC alleged that ViroPharma submitted "repetitive, serial and meritless filings" to FDA to delay the agency's approval of generic versions of the drug. The agency filed the suit in the U.S. District Court for the District of Delaware...

BCIQ Company Profiles

Shire plc

BCIQ Target Profiles

D-alanyl-D-alanine